Supplementary Figure S3 from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)